ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,489Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 247

$544K Total Retail Price of All Prescriptions

Rank: 31 out of 247

340 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 353 284 1 1
ATORVASTATIN CALCIUM 329 310 2 8
METOPROLOL TARTRATE 308 295 3 7
LEVOTHYROXINE SODIUM 240 221 4 3
OMEPRAZOLE 227 196 5 4
LOSARTAN POTASSIUM 197 172 6 15
METOPROLOL SUCCINATE 185 172 7 14
AMLODIPINE BESYLATE 181 166 8 6
LISINOPRIL 147 141 9 2
SERTRALINE HCL 143 118 10 16
GABAPENTIN 130 115 11 17
HYDROCHLOROTHIAZIDE 129 128 12 9
CLOPIDOGREL 120 113 13 70
FUROSEMIDE 111 98 14 5
PRAVASTATIN SODIUM 107 94 15 23
CYMBALTA 105 61 16 52
RAMIPRIL 101 101 17 175
TAMSULOSIN HCL 101 92 17 31
PANTOPRAZOLE SODIUM 100 88 19 19
GLIMEPIRIDE 99 84 20 80
PROAIR HFA 88 83 21 29
ADVAIR DISKUS 83 72 22 18
ATENOLOL 81 62 23 10
PLAVIX 77 72 24 106
RANITIDINE HCL 76 76 25 34
NEXIUM 75 51 26 42
TRAMADOL HCL 75 59 26 25
METFORMIN HCL ER 73 68 28 82
DIOVAN 69 63 29 38
TORSEMIDE 68 68 30 203
PAROXETINE HCL 67 46 31 45
CITALOPRAM HBR 66 65 32 20
ZOLPIDEM TARTRATE 64 57 33 24
FLUTICASONE PROPIONATE 62 53 34 37
LANSOPRAZOLE 59 36 35 166
LIPITOR 58 52 36 50
SYNTHROID 58 52 36 85
ESCITALOPRAM OXALATE 56 48 38 65
ACIPHEX 54 41 39 219
OXYBUTYNIN CHLORIDE ER 54 45 39 150
ZOSTAVAX 53 48 41 59
DILTIAZEM ER 52 45 42 108
AMITRIPTYLINE HCL 52 44 R 42 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.